30 November 2010
Venue: Willoughby Lecture Theatre, Charterhouse Square
The growth of solid cancers depends on the development of new blood vessels which invade into the tumour and feed it, a process called angiogenesis. With this in mind, if we can cut-off the cancer’s blood supply we might be able to stop the tumour from growing and spreading – a strategy known as anti-angiogenic therapy. The lecture will trace Professor Hodivala-Dilke’s research investigating the molecular control of tumour angiogenesis and the influences that have shaped her career. Kairbaan Hodivala-Dilke started her scientific career as a technical assistant, first at The Jodrell
Laboratories, Kew Gardens, and then in the Welcome Trust funded Malaria Research team at Imperial College, London. These short tastes of a scientist’s life fuelled her enthusiasm to embark on a career in research. A Biology undergraduate from the University of Southampton, in 1994, she gained a PhD after studying with Professor Fiona Watt at The Imperial Cancer Research Fund. Following Postdoctoral work with Professor Richard Hynes at The Massachusetts Institute of Technology, USA, she returned to the UK and was an Imperial Cancer Research Fund tenure-track fellow with Professor Ian Hart, first at St. Thomas’ Hospital and then, at Barts and The London School of Medicine and Dentistry. Her research is dedicated to investigating the molecular basis of angiogenesis and tumour growth.
For a map and directions to this event please click here
RSVP by email to email@example.com